Search Results

1 - 10 of 119 items :

  • T regulatory cell x
  • Clinical Medicine, other x
Clear All

, Tiegs G. Alpha-galactosylceramideinduced liver injury in mice is mediated by TNFalpha but independent of Kupffer cells. J Immunol. 2005;175:1540-50. 14. Milosavljevic N, Gazdic M, SimovicMarkovic B, Arsenijevic A, NurkovicJ,Dolicanin Z, Djonov V, Lukic ML, Volarevic V. Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells. Liver Transpl. 2017;23:1040-1050. 15. Gazdic M, Markovic BS, Arsenijevic A, Jovicic N, Acovic A, Harrell CR,Fellabaum C, Djonov V, Arsenijevic N, Lukic ML

accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets. Diabetes. 2013; 62: 1932-1944. 27. Volarevic V, Zdravkovic N, Harrell CR, Arsenijevic N, Fellabaum C, Djonov V, Lukic ML, Simovic Markovic B. Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis. Cells. 2019; 8. 28. Rad F, Ghorbani M, Mohammadi Roushandeh A, Habibi Roudkenar M. Mesenchymal stem

, Radosavljevic G, et al. Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse. J Psychiatr Res. 2012;46:1421–26. 61. Li Y, Xiao B, Qiu W, Yang L, Hu B, Tian X et al. Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder. J. Affect. Disord. 2010;124:68–75. 62. Bartrop RW, Luckhurst E, Lazarus L, Kiloh LG, Penny R. Depressed lymphocyte function after bereavement. Lancet 1977;1:834–36. 63. Eilat E, Mendlovic S, Doron A, Zakuth V, Spirer Z. Increased

with recurrent respiratory papillomatosis: incidence and risk factors. Ann Otol Rhinol Laryngol 2009;118(7):481-5. 5. Nikolova M, Lelievre JD, Carriere M, et al. Regulatory T cells modulate differentially the maturation and apoptosis of human CD8-T cell subsets. Blood 2009;113(19):4556-65. 6. Lohr J, Knoechel B, Caretto D, et al. Balance of Th1 and Th17 effector and peripheral regulatory T cells. Microbes Infect 2009;11(5):589-93. 7. Damyanov C, Terziev T, Koleva P, et al. Combined immunochemotherapy (CEPM-VEP + BCG) in the treatment of invasive bladder tumors. Anti

illness. Brain Res. 2008; 1239: 235-48. 8. Yolken RH, Torrey EF. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev. 1995; 8(1): 131-45. 9. Müller N, Riedel M, Gruber R, Manfred A. and Schwarz M. The Immune System and Schizophrenia- An Integrative View. Ann NY Acad Sci. 2000; 917: 456-67. 10. Cazzullo CL, Trabattoni D, Saresella M, Annoni G, Arosio B, Clerici M. Research on psychoimmunology. World J Biol Psychiatry. 2003; 4(3): 119-23. 11. Korn T, Anderson AC, Bettelli E, Oukka M. The dynamics of effector T cells and Foxp3+ regulatory T cells in the

. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775 - 787. 26. Numasaki M, Fukushi J-I, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze PJ. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003;101:2620-2627. 27. Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. Int J Cancer 2010;127:759-767. 28. Li MO, Sanjabi S, Flavell R. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity

, AB Wisel Pilkinson AB, et al. The clinical course of fistulating Crohn's disease. Aliment Pharmacol Ther 2003;17:1145-51. Weiner HL. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect 2001;3911:947-54. Waetzig GH, Seegert D, Rosenstiel P, et al. p38 mitogen-activated protein-kinase is activated and linked to TNF-alpha signalling in inflammatory bowel disease. J Immunol 2002;168(10):5342-51. Aghnolt J, Kaltoft K. Infliximab downregulates interferon-gamma production in activated gut Tlymphocytes from

. Slauenwhite D, Johnston B. (2015). Regulation of NKT cell localization in homeostasis and infection. Frontiers in Immunology 6:255. doi: 10.3389/fimmu.2015.00255. 13. Kumar V, Delovitch TL. (2014). Different subsets of natural killer T cells may vary in their roles in health and disease. Immunology. 142(3), 321-36. 14. Coquet JM, Kyparissoudis K, Pellicci DG, Besra G, Berzins SP, Smyth MJ, Godfrey DI. (2007). IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol. 178(5), 2827-34. 15. Marrero I, Ware R, Kumar V. (2015). Type II

. Costantino CM, Baecher-Allan C, Hafler DA. Multiple sclerosis and regulatory T cells. J Clin Immunol. 2008; 28(6): 697-706. 10. O’Connor RA, Anderton SM. Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J Neuroimmunol. 2008; 193(1-2): 1-11. 11. Zhang X, Koldzic DN, Izikson L, et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol. 2004; 16(2): 249-256. 12. LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood.2008; 112(5): 1570-1580. 13. Yanaba

. Breast Cancer Res. 2016;18(1):84. 20. DeNardo, David G., et al. “Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.” Cancer discovery 1.1 (2011): 54-67. 21. Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ. The immunosuppressive tumour network: myeloidderived suppressor cells, regulatory T cells and natural killer T cells. Immunology. 2013;138(2):105-115. 22. Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, Goncalves A, Andre P, Romagne F, Thibault G, Viens P. Human breast cancer